400-920-2911 sales@csnpharm.cn
CAS No.: 541550-19-0
Synonyms: STA 5326;LAM-002;阿匹莫德
Apilimod is a PIKfyve kinase inhibitor for treatment of B-cell non-Hodgkin lymphoma, and can block filoviral entry and infection. It can also down-regulates both IL-12 p35 and IL-12/IL-23 p40 at the transcriptional level, and inhibits the production of both IL-12 and IL-23 cytokines.
规格 | 价格 | 促销价格 | 库存 | 数量 |
---|
生物活性
动物研究 | |
剂量 | Mice: 41 mg/kg[1] (p.o.) |
给药途径 | p.o. |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT02594384 | Lymphoma, Non-Hodgkin; Leukema... more >>i, Chronic Lymphocytic Collapse << | Phase 1 | Recruiting | December 2019 | United States, Alabama ... more >> Clearview Cancer Institute Recruiting Huntsville, Alabama, United States, 35805 Contact: Avitra Bone, RN 256-705-4283 studycoordinator@ccihsv.com Principal Investigator: Marshall Schreeder, MD United States, Florida Mayo Clinic Recruiting Jacksonville, Florida, United States, 32224 Contact: Lisa Melfi 904-953-3320 melfi.lisa@mayo.edu Principal Investigator: Taimur Sher, MD United States, Georgia Winship Cancer Institute at Emory University Recruiting Atlanta, Georgia, United States, 30322 Contact: Kaylan Dixon 404-778-4449 kaylan.dixon@emory.edu Principal Investigator: Jonathan Cohen, MD United States, Indiana Horizon Oncology Research, Inc. Recruiting Lafayette, Indiana, United States, 47905 Contact: Wael A Harb, MD 765-446-5111 wharb@horizonbioadvance.com Principal Investigator: Wael A Harb, MD United States, Massachusetts Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Lauren Ramos 617-643-9607 lramos7@mgh.harvard.edu Principal Investigator: Jeremy Abramson, MD United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Corinne Parker 507-266-3784 parker.corinne@mayo.edu Principal Investigator: Stephen Ansell, MD United States, New York New York University School of Medicine Recruiting New York, New York, United States, 10016 Contact: Ion Marinescu 646-501-7920 Ion.Marinescu@nyumc.org Principal Investigator: Catherine Diefenbach, MD Weill Cornell Medical College Recruiting New York, New York, United States, 10021 Contact: Rita Gazivoda 212-746-0702 rig9021@med.cornell.edu Principal Investigator: Sarah Rutherford, MD United States, Texas University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Linda Claret 713-792-1044 lcclaret@mdanderson.org Principal Investigator: Loretta Nastoupil, MD United States, Virginia Virginia Cancer Specialists Recruiting Fairfax, Virginia, United States, 22031 Contact: VCS Phase 1 Team 703-208-3192 Karin.Choquette@usoncology.com Principal Investigator: Dipti Patel-Donnelly, MD United States, Washington Virginia Mason Medical Center Recruiting Seattle, Washington, United States, 98101 Contact: Anas Najjar 206-287-5671 Anas.Najjar@virginiamason.org Principal Investigator: David Aboulafia, MD Collapse << |
实验方案
技术信息
CAS号 | 541550-19-0 | 储存条件 |
|
|||||||
分子式 | C23H26N6O2 | 运输 | 蓝冰 | |||||||
分子量 | 418.49 | 别名 | STA 5326;LAM-002;阿匹莫德;LAM-002A free base;AIT-101 | |||||||
溶解度 |
|
动物实验配方 |